Skip to content
PICO Portalanswers from OpenAlex

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis

PaperCitations, authors & open-access status

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis is a paper indexed in PICO Portal from OpenAlex.

How many citations does Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis have?

PICO Portalcitation count

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis has 285 citations in the OpenAlex counts PICO Portal stores.

When was Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis published?

PICO Portalyear

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis has 2015 year in the PICO Portal index.

What is the open-access status of Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis?

PICO Portaloa status

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis has bronze oa status in the PICO Portal index.

What is the DOI of Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis?

PICO Portaldoi

The DOI for Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis is on the source record.

What is the PMID of Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis?

PICO Portalpmid

The PMID for Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis is on the source record.

What is the OpenAlex record for Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis?

PICO Portalopenalex

The OpenAlex for Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial